Page 4 - Babson Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEW YORK, July 5, 2021 /PRNewswire/ -- The enzyme-linked immunosorbent assay (ELISA) testing market is expected to grow by USD 265.55 million during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the market in optimistic, probable, and pessimistic forecast scenarios.  Enterprises will go through the Response, Recovery, and Renew phases. - Advertisement -   The enzyme-linked immunosorbent assay (ELISA) testing market will witness a neutral impact during the forecast period owing to the widespread growth of the COVID-1...

Babson Diagnostics, an Austin TX-based medical technology company, raised $31M in Series B funding. The round was led by Emerald Development Managers with participation from Healthineers, Prism Ventures, and Lago Consulting Group. The company intends to use the funds to expand its laboratory and ecosystem infrastructure, finalize its blood testing solution development, and grow its sales and marketing teams. In conjunction with the funding, Neil Cohen, founder and chairman of Emerald Development Managers, will join Babson’s board of directors. Originally incubated at Siemens Healthineers�...

Press release content from Business Wire. The AP news staff was not involved in its creation. Babson Diagnostics Named Fierce MedTech “Fierce 15” Company March 9, 2021 GMT AUSTIN, Texas--(BUSINESS WIRE)--Mar 9, 2021-- Babson Diagnostics (Babson), a transformative medical technology company improving customer access to diagnostic blood testing, was named one of Fierce Medtech’s elite “Fierce 15.” The honor recognizes Babson as one of the most promising private companies in the global healthcare industry. In the year of COVID-19, Fierce Medtech, a leading daily digital news publicatio...

Share: New York, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "COVID-19 Diagnostics Market - Global Outlook and Forecast 2021-2026" - https://www.reportlinker.com/p05995439/?utm_source=GNW The RT-PCR testing segment constituted over 75% of the global COVID diagnostics market share. The market is growing because of the outbreak of the coronavirus (SARS CoV-2) pandemic, which has increased the demand for rapid testing across the world. As the number of people suffering from the viral infection increases, the demand for rapid testing, which allows dete...

| Press Release The global COVID-19 diagnostics market by revenue is expected to register a negative CAGR of (9%) during the period 2021–2026 New York, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "COVID-19 Diagnostics Market - Global Outlook and Forecast 2021-2026" - https://www.reportlinker.com/p05995439/?utm_source=GNW The RT-PCR testing segment constituted over 75% of the global COVID diagnostics market share. The market is growing because of the outbreak of the coronavirus (SARS CoV-2) pandemic, which has increased the demand for rapid tes...